DE2121648C3 - Monoacetate der Antibiotica SF-837 und SF 837-A tief 2 - Google Patents
Monoacetate der Antibiotica SF-837 und SF 837-A tief 2Info
- Publication number
- DE2121648C3 DE2121648C3 DE2121648A DE2121648A DE2121648C3 DE 2121648 C3 DE2121648 C3 DE 2121648C3 DE 2121648 A DE2121648 A DE 2121648A DE 2121648 A DE2121648 A DE 2121648A DE 2121648 C3 DE2121648 C3 DE 2121648C3
- Authority
- DE
- Germany
- Prior art keywords
- substance
- monoacetates
- mixture
- reaction
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- DMUAPQTXSSNEDD-QALJCMCCSA-N Midecamycin Chemical compound C1[C@](O)(C)[C@@H](OC(=O)CC)[C@H](C)O[C@H]1O[C@H]1[C@H](N(C)C)[C@@H](O)[C@H](O[C@@H]2[C@H]([C@H](OC(=O)CC)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@@H]2CC=O)OC)O[C@@H]1C DMUAPQTXSSNEDD-QALJCMCCSA-N 0.000 title claims description 38
- 239000003242 anti bacterial agent Substances 0.000 title claims description 7
- 229940088710 antibiotic agent Drugs 0.000 title claims description 7
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 239000000126 substance Substances 0.000 description 44
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 15
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 15
- 230000007062 hydrolysis Effects 0.000 description 13
- 238000006460 hydrolysis reaction Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 7
- 239000012458 free base Substances 0.000 description 7
- ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 239000004187 Spiramycin Substances 0.000 description 6
- 241000193996 Streptococcus pyogenes Species 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 6
- 229960001294 spiramycin Drugs 0.000 description 6
- 229930191512 spiramycin Natural products 0.000 description 6
- 235000019372 spiramycin Nutrition 0.000 description 6
- YAQOKDYFTLGDSF-HWYPZJCRSA-N [(2R,3R,4S)-6-[(2S,3R,4R,5S,6R)-5-acetyloxy-6-[[(4S,5R,6R,7S,9S,10S,11E,13E,16S)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] butanoate Chemical compound CCCC(=O)O[C@@H]1[C@@H](C)OC(C[C@]1(C)O)O[C@H]1[C@H](C)O[C@H](O[C@@H]2[C@H](CC=O)C[C@H](C)[C@H](O)\C=C\C=C\C[C@H](C)OC(=O)C[C@H](OC(C)=O)[C@H]2OC)[C@@H](OC(C)=O)[C@@H]1N(C)C YAQOKDYFTLGDSF-HWYPZJCRSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 239000012429 reaction media Substances 0.000 description 3
- 238000007127 saponification reaction Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 229910000906 Bronze Inorganic materials 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 101000599862 Homo sapiens Intercellular adhesion molecule 3 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical class [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000187480 Mycobacterium smegmatis Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000577483 Salmonella enterica subsp. enterica serovar Paratyphi B Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000194024 Streptococcus salivarius Species 0.000 description 1
- TYYIFWXTQAQRHI-MDWYKHENSA-N [(2s,3s,4r,6s)-6-[(2r,3s,4r,5r,6s)-4-(dimethylamino)-5-hydroxy-6-[[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-4-propanoyloxy-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyl Chemical compound C1[C@](O)(C)[C@@H](OC(=O)CCC)[C@H](C)O[C@H]1O[C@H]1[C@H](N(C)C)[C@@H](O)[C@H](O[C@@H]2[C@H]([C@H](OC(=O)CC)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@@H]2CC=O)OC)O[C@@H]1C TYYIFWXTQAQRHI-MDWYKHENSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- -1 aliphatic alcohols Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000010974 bronze Substances 0.000 description 1
- 238000002815 broth microdilution Methods 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3745670 | 1970-05-04 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2121648A1 DE2121648A1 (de) | 1971-12-02 |
| DE2121648B2 DE2121648B2 (de) | 1974-03-07 |
| DE2121648C3 true DE2121648C3 (de) | 1974-10-10 |
Family
ID=12498005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2121648A Expired DE2121648C3 (de) | 1970-05-04 | 1971-05-03 | Monoacetate der Antibiotica SF-837 und SF 837-A tief 2 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3792035A (https=) |
| BE (1) | BE766710A (https=) |
| CA (1) | CA931142A (https=) |
| CH (1) | CH557348A (https=) |
| DE (1) | DE2121648C3 (https=) |
| FR (1) | FR2100626B1 (https=) |
| GB (1) | GB1325943A (https=) |
| NL (1) | NL165177C (https=) |
| SE (1) | SE393987B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS563359B2 (https=) * | 1972-04-06 | 1981-01-24 | ||
| US3932383A (en) * | 1974-06-03 | 1976-01-13 | Abbott Laboratories | 9-Dihydroniddamycin A compounds and related 3-(O)-esters and the process for their preparation |
| US3970642A (en) * | 1974-06-03 | 1976-07-20 | Abbott Laboratories | Process for the conversion of niddamycin to leucomycin A1, leucomycin A3, carbomycin B and other antibiotics and related 3-O-esters |
| JPS5126887A (en) * | 1974-08-27 | 1976-03-05 | Meiji Seika Co | Koseibutsushitsu sff837m1 butsushitsuno 9*3**4* toriashirujudotaino seizoho |
| US3959256A (en) * | 1974-09-12 | 1976-05-25 | Meiji Seika Kaisha, Ltd. | 9-O-Alkanoyl-3"-O-alkanoyloxymethyl-SF-837 substance and the production thereof |
| US4980992A (en) * | 1989-10-13 | 1991-01-01 | Overhead Door Corporation | Revolving door assembly with foldable door wings |
| WO2000073317A1 (fr) * | 1999-06-01 | 2000-12-07 | Meiji Seika Kaisha, Ltd. | Derives de leucomycine modifiee en position 3 |
-
1971
- 1971-04-21 US US00135858A patent/US3792035A/en not_active Expired - Lifetime
- 1971-04-23 CA CA111201A patent/CA931142A/en not_active Expired
- 1971-04-26 GB GB1134071*[A patent/GB1325943A/en not_active Expired
- 1971-04-29 SE SE7105603A patent/SE393987B/xx unknown
- 1971-05-03 DE DE2121648A patent/DE2121648C3/de not_active Expired
- 1971-05-03 FR FR7115759A patent/FR2100626B1/fr not_active Expired
- 1971-05-04 BE BE766710A patent/BE766710A/xx not_active IP Right Cessation
- 1971-05-04 NL NL7106090.A patent/NL165177C/xx not_active IP Right Cessation
- 1971-05-04 CH CH659971A patent/CH557348A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2100626A1 (https=) | 1972-03-24 |
| SE393987B (sv) | 1977-05-31 |
| BE766710A (fr) | 1971-10-01 |
| NL165177C (nl) | 1981-03-16 |
| US3792035A (en) | 1974-02-12 |
| DE2121648B2 (de) | 1974-03-07 |
| GB1325943A (en) | 1973-08-08 |
| DE2121648A1 (de) | 1971-12-02 |
| FR2100626B1 (https=) | 1974-05-24 |
| CA931142A (en) | 1973-07-31 |
| NL7106090A (https=) | 1971-11-08 |
| NL165177B (nl) | 1980-10-15 |
| CH557348A (de) | 1974-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1770033A1 (de) | Neue Derivate von Cephalosporin C und Verfahren zu ihrer Herstellung(II) | |
| DE2154436A1 (de) | Partricin-methylester | |
| DE2121648C3 (de) | Monoacetate der Antibiotica SF-837 und SF 837-A tief 2 | |
| DE2406628A1 (de) | Alkylester von partricin, verfahren zu ihrer herstellung und diese ester enthaltende pharmazeutische mittel | |
| DE2537375A1 (de) | 9,3'',4''-triacylester des antibiotikums sf-837 m tief 1 sowie verfahren zur herstellung derselben | |
| DE2004686B2 (de) | Makrolid-Antibioticum SF-837 und dessen Diacetylderivat und deren pharmakologisch nichtgiftige Säureanlagerungssalze sowie Verfahren zur Herstellung des Antibioticums SF-837 | |
| DE2014277C3 (de) | Verfahren zur Herstellung von Acylderivaten des Antibiotikums T-2636 C | |
| DE2706156C3 (de) | N,N,N-Trimethylderivate amphoterer, antimykotischer Polyenantibiotika und Verfahren zu deren Herstellung | |
| DE2316705C3 (de) | 9-Acyl -3' '-thiomethoxymethyl-SF-837-Macrolid-Antibiotika, Verfahren zur Herstellung derselben sowie diese enthaltende pharmazeutische Mittel | |
| DE1814735C3 (https=) | ||
| CH630411A5 (en) | Process for preparing dihydromocimycin | |
| DE2621615C3 (de) | Dihydromocimycin, seine Salze, Verfahren zu seiner Herstellung und seine Verwendung als Futtermittelzusatz | |
| DE972336C (de) | Verfahren zur Gewinnung von stabilen, besonders fuer die Oraltherapie geeigneten Penicillinen | |
| DE2336397A1 (de) | Alkylester von polyen-antibiotika | |
| EP0432309B1 (de) | Neue Zuckerderivate, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE882139C (de) | Verfahren zur Herstellung eines Antibiotikums | |
| DE3308408C2 (de) | 3"-Desoxystreptomycin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende antibakterielle Zusammensetzungen | |
| AT247519B (de) | Verfahren zur Herstellung neuer Additionsverbindungen von Antibiotika | |
| DE1938437C3 (de) | Verfahren zur Herstellung von Levorinnatriumsalz | |
| DE2949594C2 (de) | Kanamycintannat, Verfahren zu seiner Hersellung und pharmazeutische Mittel | |
| DE2659180C2 (de) | Antibiotisches Derivat der Substanz SF-1540 und Verfahren zu dessen Herstellung | |
| DE1492111C (de) | Verfahren zur Herstellung von Poly oxm A und B | |
| DE1593317C3 (de) | Verfahren zur Herstellung eines Wismut-Aluminium-Doppelpektates | |
| DE2418777A1 (de) | Halbester des siomycins a, ihre salze, verfahren zu ihrer herstellung und arzneimittel | |
| DE2445195B2 (de) | 9-0-acyl-3''-0-acyloxymethylderivate des antibioticums sf-837 sowie verfahren zur herstellung derselben |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| E77 | Valid patent as to the heymanns-index 1977 |